"Eiger Announces Both #lonafarnib based Treatments in Pivotal Phase 3 D-LIVR Trial in Hepatitis Delta Virus #HDV Achieved Statistical Significance Against Placebo in Composite Primary Endpoint https://t.co/yjIhFgARDP"

Zokinvy (lonafarnib) - Eiger

Dec 19, 2022